(Q36655269)

15 August 2017

1 reference

title

Rimonabant: endocannabinoid inhibition for the metabolic syndrome (English)

1 reference

15 August 2017

0 references

1 reference

A S Wierzbicki

1

1 reference

PubMed ID

17109677

15 August 2017

language of work or name

1 reference

1 December 2006

1 reference

International Journal of Clinical Practice

15 August 2017

1 reference

15 August 2017

60

1 reference

15 August 2017

12

1 reference

15 August 2017

1697-1706

1 reference

Meta-analysis: pharmacologic treatment of obesity

15 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

Cannabinoids and the regulation of ingestive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

Endocannabinoids and the regulation of body fat: the smoke is clearing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

Food for thought: endocannabinoid modulation of lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2006.01210.X

10.1111/J.1742-1241.2006.01210.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17109677